EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic value of galactomannan in tracheobronchial aspirate for Aspergillus infection in lung transplant recipients (the GALACTBAS study)

Arnau Monforte iD, Maria Teresa Martín-Gómez iD, Cristina Berastegui iD, Ester Márquez-Algaba, Judith Sacanell, Joel Rosado, Anna Falcó-Roget iD, Gonzalo Escudero iD, Jose Casanovas, Cristina Kirkegaard-Biosca iD, Berta Sáez-Giménez iD, Víctor Monforte iD und 3 weitere

Journal of Clinical Microbiology · 10.06.2026 · 64 (6)

DOI: 10.1128/jcm.01556-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 10.06.2026. Verfasst von Arnau Monforte und 14 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus…. Hauptthemen laut MEDLINE: Mannans, Lung Transplantation, Bronchoalveolar Lavage Fluid, Transplant Recipients. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck & Co. | MSD Sharp and Dohme (MSD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung transplant recipients (LTR) are highly susceptible to Aspergillus infection (AI), but diagnosis may be limited by the invasiveness of bronchoalveolar lavage fluid (BALF) collection. Proximal airway samples may provide a less invasive alternative. We conducted a retrospective single-center study including all adult LTR (March 2018–March 2022) who underwent bronchoscopy with tracheobronchial aspirate (TBA) and BALF galactomannan (GM) testing in the same procedure. They were processed for mycological culture and EIA-based GM (Bio-Rad) after cysteine homogenization. AI was defined according to ISHLT consensus. A ROC curve for TBA GM and its diagnostic performance were assessed. A total of 545 paired TBA–BALF samples from 282 LTR were analyzed. Proven or probable AI was diagnosed in 22 samples (4%). The optimal TBA GM cut-off was ≥0.54 optical density index (ODI), yielding 95.2% sensitivity, 92% specificity, and an AUC of 0.97 (95% CI, 0.95–0.99). In comparison, BALF GM at ≥1.0 ODI showed 33.3% sensitivity and 99.6% specificity (AUC 0.88, 95% CI, 0.80–0.95) although BALF GM values were significantly higher in invasive infections compared with non-invasive infections (1.49 vs 0.14; P -value = 0.007). TBA cultures were more frequently positive than BALF (24% vs 9.9%). Finally, TBA and BALF GM values demonstrated moderate correlation ( r = 0.54), and combined testing with concordant results improved accuracy to 99.6%. TBA GM demonstrated higher sensitivity than BALF GM for detecting AI in LTR, while maintaining high specificity. Proximal airway samples could complement BALF in future diagnostic strategies. IMPORTANCE This study provides evidence that galactomannan antigen testing (GM) in tracheobronchial aspirate (TBA) is a highly sensitive, reliable, and less invasive diagnostic tool for detecting Aspergillus infection in lung transplant recipients under universal antifungal prophylaxis, compared to the current standard bronchoalveolar lavage fluid (BALF) GM. These findings highlight the diagnostic value of proximal airway specimens, consistent with the pathophysiology of post-transplant aspergillosis, which often originates in the bronchial tree and may not be adequately captured by BALF early in the disease course. Importantly, the study shows that combining TBA and BALF GM results yields near-perfect diagnostic accuracy, supporting a complementary diagnostic strategy rather than a replacement approach. Although this is a proof-of-concept study, it fills a critical evidence gap in transplant infectious diseases and lays the groundwork for safer, more accurate, and earlier diagnosis of Aspergillus infection, with potential implications for clinical practice, antifungal stewardship, and future guideline development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MannansLung TransplantationBronchoalveolar Lavage FluidTransplant RecipientsAspergillosisHumansGalactoseFemaleRetrospective StudiesMaleSensitivity and SpecificityMiddle AgedAdultAspergillusBronchoscopyTracheaROC CurveAged

Stichwörter der Autor:innen

fungal biomarkersfungal infectioninvasive aspergillosislung transplantationpulmonary aspergillosis

Substanzen

MannansGalactosegalactomannan

Autor:innen und Institutionen

  • Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Microbiology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Intensive Care Department, Hospital Universitari Vall d'Hebron, SODIR Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

ORCID-Profile: Arnau Monforte, Maria Teresa Martín-Gómez, Cristina Berastegui, Anna Falcó-Roget, Gonzalo Escudero, Cristina Kirkegaard-Biosca, Berta Sáez-Giménez, Víctor Monforte, Ibai Los-Arcos

Förderung

  • Merck & Co. | MSD Sharp and Dohme (MSD)

Zitieren

APA

Monforte, A., Martín-Gómez, M. T., Berastegui, C., Márquez-Algaba, E., Sacanell, J., Rosado, J., Falcó-Roget, A., Escudero, G., Casanovas, J., Kirkegaard-Biosca, C., Sáez-Giménez, B., Monforte, V., Gavaldà, J., Len, O., & Los-Arcos, I. (2026). Diagnostic value of galactomannan in tracheobronchial aspirate for Aspergillus infection in lung transplant recipients (the GALACTBAS study). Journal of Clinical Microbiology, 64(6). https://doi.org/10.1128/jcm.01556-25

Vancouver

Monforte A, Martín-Gómez MT, Berastegui C, Márquez-Algaba E, Sacanell J, Rosado J, et al. Diagnostic value of galactomannan in tracheobronchial aspirate for Aspergillus infection in lung transplant recipients (the GALACTBAS study). Journal of Clinical Microbiology. 2026;64(6). doi:10.1128/jcm.01556-25

BibTeX
@article{Monforte2026,
  author = {Monforte, Arnau and Martín-Gómez, Maria Teresa and Berastegui, Cristina and Márquez-Algaba, Ester and Sacanell, Judith and Rosado, Joel and Falcó-Roget, Anna and Escudero, Gonzalo and Casanovas, Jose and Kirkegaard-Biosca, Cristina and Sáez-Giménez, Berta and Monforte, Víctor and Gavaldà, Joan and Len, Oscar and Los-Arcos, Ibai},
  title = {Diagnostic value of galactomannan in tracheobronchial aspirate for Aspergillus infection in lung transplant recipients (the GALACTBAS study)},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  volume = {64},
  number = {6},
  doi = {10.1128/jcm.01556-25}
}
Kostenlos starten →